Jonathan Krell
Imperial College London
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jonathan Krell as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:06 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04599608 · Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic PatientsImperial College London · unknown · Advanced Cancer, Metastatic Cancer · principal investigator
- Ph1NCT03934827 · MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the TumourImperial College London · unknown · Melanoma, Breast Cancer, Uterine Cancer · principal investigator
- Ph2NCT03648489 · Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Imperial College London · completed · Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:06 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer.JAMA Surg · 201479 citationsRCR 2.5
- Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.Br J Cancer · 201254 citationsRCR 1.4
- 54 citationsRCR 2.8
- Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.Int J Dermatol · 201637 citationsRCR 1.6
- Comparison of the Ferno Scoop Stretcher with the long backboard for spinal immobilization.Prehosp Emerg Care · 200630 citationsRCR 1.5
- 28 citationsRCR 2.2
- Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.JAMA Dermatol · 202426 citationsRCR 5.6
- 22 citationsRCR 0.6
- An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis.J Am Acad Dermatol · 200817 citationsRCR 0.7
- A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.Gynecol Oncol · 202312 citationsRCR 1.0